Riyadh, Saudi Arabia 10/12/2024— MS Pharma, a leader in pharmaceutical innovation across the Middle East and North Africa, showcased its cutting-edge biologics portfolio and state-of-the-art biosimilar manufacturing facility at CPhI Middle East 2024. The event, held from December 10–12 at the Riyadh Front Exhibition & Convention Center, is recognized as the premier gathering for global pharmaceutical leaders.

Riyadh, Saudi Arabia – MS Pharma, a leading pharmaceutical company in the MENA region, has signed an Industry Localization and Knowledge Transfer Agreement with the Local Content and Government Procurement Authority (LCGPA) in Saudi Arabia. The agreement, formalized during the Local Content Forum 2024 in Riyadh, marks an important milestone with the inclusion of the Ranibizumab liquid vial product in the Mandatory List.

MS Pharma has partnered with Saudi Arabia’s LCGPA to localize production and share expertise. The agreement, announced at the 2024 Local Content Forum in Riyadh, adds the Ranibizumab liquid vial to the Mandatory List.